3
Views
9
CrossRef citations to date
0
Altmetric
Original Article

Influence of Chronic Treatment with Neomycin and Kanamycin on N1 Suppression Produced by Contralateral Olivo-Cochlear Bundle Stimulation in Cats

Pages 335-340 | Received 13 Apr 1971, Published online: 08 Jul 2009
 

Abstract

Twenty cats received one subcutaneous injection per day of neomycin sulfate (100 mg/kg/day) and 5, kanamycin sulfate (200 mg/kg/day) for 8 days; experiments were performed on the ninth day. Nine of 10 untreated control, 13 of 20 neomycin and 5 of 5 kanamycin animals had normal cochlear responses to acoustic stimulation and were usable for this study. The efficacy of contralateral olivo-cochlear bundle (COCB) stimulation was determined at 400 (optimally effective) and 100 (minimally effective) Hz for 4 different current strengths at each frequency of stimulation. Six of the neomycin animals exhibited a significant block of COCB stimulation effects at all currents and both frequencies of stimulation, while the other 7 neomycin animals and the kanamycin animals showed a significant increase in the effectiveness of COCB stimulation at the lower currents of the higher (optimal) stimulation frequency. Thus, chronic treatment with neomycin and kanamycin produces changes in COCB stimulation effects, indicating that alterations of cochlear efferent function may be playing a role in the genesis of the ototoxicity produced by certain Streptomyces antibiotics.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.